Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.
暂无分享,去创建一个
A. Rudich | N. Bashan | S. Fishman | E. Lewis | S. Wueest | O. Nov | D. Konrad | S. Ben-Shlomo | A. Kohl | I. Dvir
[1] P. Venieratos,et al. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells. , 2010, Cellular signalling.
[2] A. Chervonsky,et al. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. , 2010, The Journal of clinical investigation.
[3] S. Schinner,et al. Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2009 .
[4] A. Mora,et al. A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.
[5] H. Tilg,et al. Insulin resistance, inflammation, and non-alcoholic fatty liver disease , 2008, Trends in Endocrinology & Metabolism.
[6] E. Verna,et al. Role of Fatty Acids in the Pathogenesis of Obesity and Fatty Liver: Impact of Bariatric Surgery , 2008, Seminars in liver disease.
[7] L. Ivashkiv,et al. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes , 2008, Nature Immunology.
[8] A. Kotronen,et al. Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. , 2008, The Journal of clinical endocrinology and metabolism.
[9] J. Yudkin,et al. Inflammation, Obesity, and the Metabolic Syndrome , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[10] J. Eckel,et al. Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes , 2007, FEBS letters.
[11] E. Maury,et al. Adipokines oversecreted by omental adipose tissue in human obesity. , 2007, American journal of physiology. Endocrinology and metabolism.
[12] M. Stumvoll,et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.
[13] Laura Herrero,et al. Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.
[14] Allan Vaag,et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.
[15] S. Saadeh. Nonalcoholic Fatty liver disease and obesity. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[16] Y. Le Marchand-Brustel,et al. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.
[17] K. Clément,et al. Review article: Is obesity an inflammatory illness? Role of low‐grade inflammation and macrophage infiltration in human white adipose tissue , 2006 .
[18] J. Tanti,et al. Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress , 2006, Diabetologia.
[19] J. Capeau,et al. Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes , 2006, Diabetologia.
[20] J. Lv,et al. Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. , 2006, Biochemical and biophysical research communications.
[21] Avner Bar Hen,et al. Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity , 2006, Diabetes.
[22] K. Clément,et al. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. , 2006, BJOG : an international journal of obstetrics and gynaecology.
[23] T. Suganami,et al. A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[24] B. Ustundag,et al. Proinflammatory Cytokines and Leptin Are Increased in Serum of Prepubertal Obese Children , 2005, Mediators of inflammation.
[25] A. Syrenicz,et al. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. , 2005, Neuro endocrinology letters.
[26] S. B. Pedersen,et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.
[27] J. Jenkins,et al. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α , 2005 .
[28] B. Wisse,et al. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. , 2004, Journal of the American Society of Nephrology : JASN.
[29] V. Giusti,et al. Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. , 2004, The Journal of clinical endocrinology and metabolism.
[30] A. Madan,et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.
[31] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[32] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[33] R. Bergman,et al. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. , 2003, Diabetes.
[34] V. Giusti,et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. , 2003, Diabetes.
[35] Joachim Spranger,et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.
[36] H. Hauner,et al. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. , 2002, Diabetes.
[37] J. Holder,et al. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. , 2002, Diabetes.
[38] P. Arner. Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.
[39] M. Lane,et al. Cross-talk between sympathetic neurons and adipocytes in coculture , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Barnett,et al. Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. , 2001, The Journal of clinical endocrinology and metabolism.
[41] A. Rudich,et al. Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-α in 3T3-L1 adipocytes , 2001, Diabetologia.
[42] A. Rudich,et al. Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.
[43] S. Souza,et al. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. , 1998, Diabetes.
[44] G. Shulman,et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.
[45] G. Michalopoulos,et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.
[46] M. Papa,et al. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. , 1993, The Journal of biological chemistry.
[47] R. DeFronzo,et al. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.
[48] D. Friend,et al. HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, Journal of Cell Biology.